These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9663892)
1. Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy. van Guldener C; Janssen MJ; Lambert J; ter Wee PM; Donker AJ; Stehouwer CD Perit Dial Int; 1998; 18(3):282-9. PubMed ID: 9663892 [TBL] [Abstract][Full Text] [Related]
2. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients. van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520 [TBL] [Abstract][Full Text] [Related]
3. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients. van Guldener C; Janssen MJ; Lambert J; ter Wee PM; Jakobs C; Donker AJ; Stehouwer CD Nephrol Dial Transplant; 1998 Jan; 13(1):106-12. PubMed ID: 9481724 [TBL] [Abstract][Full Text] [Related]
4. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Thambyrajah J; Landray MJ; McGlynn FJ; Jones HJ; Wheeler DC; Townend JN Circulation; 2000 Aug; 102(8):871-5. PubMed ID: 10952955 [TBL] [Abstract][Full Text] [Related]
5. Treatment of hyperhomocysteinemia in children on dialysis by folic acid. Schröder CH; de Boer AW; Giesen AM; Monnens LA; Blom H Pediatr Nephrol; 1999 Sep; 13(7):583-5. PubMed ID: 10460506 [TBL] [Abstract][Full Text] [Related]
6. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?]. Lovcić V; Kes P; Zeljko R; Kusec V Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832 [TBL] [Abstract][Full Text] [Related]
7. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Doshi SN; McDowell IF; Moat SJ; Payne N; Durrant HJ; Lewis MJ; Goodfellow J Circulation; 2002 Jan; 105(1):22-6. PubMed ID: 11772871 [TBL] [Abstract][Full Text] [Related]
8. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. Mangoni AA; Sherwood RA; Swift CG; Jackson SH J Intern Med; 2002 Dec; 252(6):497-503. PubMed ID: 12472909 [TBL] [Abstract][Full Text] [Related]
9. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease. Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646 [TBL] [Abstract][Full Text] [Related]
10. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. McGregor DO; Dellow WJ; Lever M; George PM; Robson RA; Chambers ST Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830 [TBL] [Abstract][Full Text] [Related]
11. Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients. Obeid R; Kuhlmann MK; Köhler H; Herrmann W Clin Chem; 2005 Jan; 51(1):196-201. PubMed ID: 15528294 [TBL] [Abstract][Full Text] [Related]
12. Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure. McGregor DO; Dellow WJ; Robson RA; Lever M; George PM; Chambers ST Kidney Int; 2002 Mar; 61(3):1040-6. PubMed ID: 11849459 [TBL] [Abstract][Full Text] [Related]
13. Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation. Bostom AG; Shemin D; Nadeau MR; Shih V; Stabler SP; Allen RH; Selhub J Atherosclerosis; 1995 Feb; 113(1):129-32. PubMed ID: 7755649 [No Abstract] [Full Text] [Related]
14. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial. Ossareh S; Shayan-Moghaddam H; Salimi A; Asgari M; Farrokhi F Iran J Kidney Dis; 2009 Oct; 3(4):227-33. PubMed ID: 19841527 [TBL] [Abstract][Full Text] [Related]
15. [Effects of folic acid supplementation on hyperhomocysteinemia in CAPD patients: effects on unsaturated fatty acids]. Hirose S; Kim S; Matsuda A; Itakura Y; Matsumura O; Tamura H; Nagasawa R; Mitarai T; Isoda K Nihon Jinzo Gakkai Shi; 1998 Jan; 40(1):8-16. PubMed ID: 9513377 [TBL] [Abstract][Full Text] [Related]
16. Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy. van Guldener C; Lambert J; ter Wee PM; Donker AJ; Stehouwer CD Clin Nephrol; 2000 Jan; 53(1):33-41. PubMed ID: 10661480 [TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. Thambyrajah J; Landray MJ; Jones HJ; McGlynn FJ; Wheeler DC; Townend JN J Am Coll Cardiol; 2001 Jun; 37(7):1858-63. PubMed ID: 11401123 [TBL] [Abstract][Full Text] [Related]
18. Difference in the homocysteine-lowering effect of folic acid in haemodialysis patients with and without occlusive vascular disease. Descombes E; Boulat O; Bersier LF; Fellay G Nephrol Dial Transplant; 2001 Mar; 16(3):585-9. PubMed ID: 11239036 [TBL] [Abstract][Full Text] [Related]
19. Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease. Yilmaz H; Sahin S; Sayar N; Tangurek B; Yilmaz M; Nurkalem Z; Onturk E; Cakmak N; Bolca O Acta Cardiol; 2007 Dec; 62(6):579-85. PubMed ID: 18214123 [TBL] [Abstract][Full Text] [Related]
20. Treatment with different doses of folic acid in haemodialysis patients: effects on folate distribution and aminothiol concentrations. Arnadottir M; Gudnason V; Hultberg B Nephrol Dial Transplant; 2000 Apr; 15(4):524-8. PubMed ID: 10727548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]